---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003091"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:49:12.081981+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences announces 1-for-15 reverse stock split effective Jan 27, 2025

## Summary
- Shareholders approved reverse split at a special meeting on Jan 17, 2025; ratio range 1:10 to 1:100.
- Board set ratio at 1-for-15; outstanding shares to reduce from ~10.4M to ~692,580.
- No fractional shares; rounding up to next whole number; authorized shares remain 100M.
- Trading symbol ENVB unchanged; new CUSIP 29405E 406; adjusted trading begins Jan 27.

## SEC filing metadata
- accession: 0001493152-25-003091
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/0001493152-25-003091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003091
- JSON: https://secwatch.observer/filing/0001493152-25-003091.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.